Scientists launch 5-Year quest to unlock CMT1A's secrets
NCT ID NCT06794489
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 75 adults with CMT1A and 25 healthy volunteers over five years to track how the disease progresses. Researchers will analyze blood and skin samples to find biomarkers that could make future clinical trials faster and more reliable. The goal is to better understand why symptoms vary so much between patients and to build a tissue bank for ongoing research.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could identify reliable biomarkers that make it easier to test new treatments for CMT1A in future clinical trials.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly improve symptoms, and the biomarkers identified may not prove useful in later drug studies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CMT (CHARCOT MARIE TOOTH DISEASE) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Medical Centre
RECRUITINGGöttingen, Lower Saxony, 37075, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.